ArticleJournal of family & community medicine
Epidemiology of reportable infectious diseases in the Najran Health Cluster.
Article in Journal of family & community medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo control disease outbreaks and promote the prevention of disease, monitoring the burden of infectious illnesses and their epidemiology is essential. Keeping track of changes in disease rates and, more crucially, the effectiveness of control measures like immunization campaigns for the eradication of certain infectious illnesses depends heavily on national surveillance data. MATERIALS AND
methodsThis study analyzed national surveillance data to illustrate the evolving epidemiology of reportable infectious diseases in the Najran Health Cluster from 2022 to 2024. For each disease, incidence rate (per 100,000 population) with a 95% confidence interval were calculated using population census data from 2022 to 2024. For each year, number of cases were described by sex, nationality, and age. Statistical analysis were performed using SPSS; Pearson's Chi-Square and Fisher's exact tests assessed the association between disease incidence and population demographics.
resultsThe most common bacterial diseases were brucellosis, pulmonary tuberculosis, and salmonellosis. In 2024, there were outbreaks of pertussis and cholera (incidence rate 5.2 and 7.6/100,000, respectively). The most common viral diseases were measles, hepatitis B, dengue fever, and chickenpox. In 2024, there was a marked increase in the number of confirmed hepatitis B cases, from 100 cases in 2023 to 256 in 2024. The most common parasitic diseases were scorpion sting, malaria, cutaneous leishmaniasis, and amebic dysentery. The number of reported cases of malaria almost doubled from 45 in 2023 to 88 in 2024.
conclusionThe study highlights the importance of tracing infectious disease data to identify outbreaks early and implement control measures. In 2024, there was an increase in the number of confirmed cases of hepatitis B, pertussis, cholera, and malaria, a situation that requires urgent investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.